In several brain diseases (like Multiple Sclerosis, and ischemic stroke) among humans, IFN-γ is present at relatively high concentrations (∼1000 pg/ml) in the cerebrospinal fluid [58] and understanding the interactions between soluble mediators produced by T-cells and is critical to developing therapeutic approaches, particularly when using stem cells. The gene discussed is IFNG; the disease is brain disorder.